Literature DB >> 32340854

Mild Encephalitis/Encephalopathy with reversible splenial lesion syndrome: An unusual presentation of anti-GFAP astrocytopathy.

Valentin Oger1, Chloé Bost2, Lucie Salah1, Elise Yazbeck1, Hélène Maurey1, Céline Bellesme1, Caroline Sevin1, Catherine Adamsbaum3, Pascale Chrétien4, Marie Benaiteau5, Jérôme Honnorat6, Kumaran Deiva7.   

Abstract

Autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy is a rare recently defined antibody-mediated encephalitis. Meningo-encephalomyelitis presentation is frequent with lymphocytic pleiocytosis in the cerebro-spinal fluid and brain MRI classically demonstrates in 50% of cases, a linear perivascular enhancement extending radially from the ventricles. Here, we describe 2 cases of pediatric autoimmune GFAP astrocytopathy with limbic encephalitis presentation and peculiar MRI characteristics: one with normal MRI and the second suggestive of Mild Encephalitis/Encephalopathy with reversible splenial lesion syndrome (MERS). These two cases illustrate that anti-GFAP antibodies should be sought in children presenting limbic encephalitis with a normal and/or MERS suggestive MRI, as treatment strategies may differ.
Copyright © 2020 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Astrocytopathy; Auto immun; Autoantibody; Central nervous system; Encéphalitis; GFAP; Glial fibrillary acidic protein; IRM

Mesh:

Substances:

Year:  2020        PMID: 32340854     DOI: 10.1016/j.ejpn.2020.03.002

Source DB:  PubMed          Journal:  Eur J Paediatr Neurol        ISSN: 1090-3798            Impact factor:   3.140


  6 in total

1.  Anti-MDA5 antibody-positive dermatomyositis with mild encephalopathy with reversible splenial lesion: a possible rare association?

Authors:  Khadija Saghir; Mohammed Chraa; Najib Kissani; Hajar Joulal; Lamiaa Essaadouni; Nissrine Louhab
Journal:  Wien Med Wochenschr       Date:  2022-06-21

2.  The Clinical Spectrum of Autoimmune-Mediated Neurological Diseases in Paediatric Population.

Authors:  Karol Lubarski; Anna Mania; Sławomir Michalak; Krystyna Osztynowicz; Katarzyna Mazur-Melewska; Magdalena Figlerowicz
Journal:  Brain Sci       Date:  2022-04-29

3.  Anti-glial fibrillary acidic protein antibodies as a cause of reversible splenial lesion syndrome (RESLES): a case report.

Authors:  Kundian Guo; Xiaohui Lai; Yue Liu; Dong Zhou; Zhen Hong
Journal:  Neurol Sci       Date:  2021-06-05       Impact factor: 3.307

4.  Glial Fibrillary Acidic Protein Autoimmunity: A French Cohort Study.

Authors:  Alice Gravier-Dumonceau; Roxana Ameli; Veronique Rogemond; Anne Ruiz; Bastien Joubert; Sergio Muñiz-Castrillo; Alberto Vogrig; Geraldine Picard; Aditya Ambati; Marie Benaiteau; Florence Rulquin; Jonathan Ciron; Kumaran Deiva; Thomas de Broucker; Laurent Kremer; Philippe Kerschen; François Sellal; Bastien Bouldoires; Roxana Genet; Julien Biberon; Adrien Bigot; Fanny Duval; Nahema Issa; Elena-Camelia Rusu; Mathilde Goudot; Anais Dutray; Jean Louis Devoize; Lucie Hopes; Anne-Laure Kaminsky; Marion Philbert; Eve Chanson; Amelie Leblanc; Erwan Morvan; Daniela Andriuta; Philippe Diraison; Gabriel Mirebeau; Celine Derollez; Veronique Bourg; Quentin Bodard; Clementine Fort; Irina Grigorashvili-Coin; Guillaume Rieul; Daniela Molinier-Tiganas; Mickaël Bonnan; Thierry Tchoumi; Jérôme Honnorat; Romain Marignier
Journal:  Neurology       Date:  2021-11-19       Impact factor: 9.910

5.  Characteristics of Movement Disorders in Patients with Autoimmune GFAP Astrocytopathy.

Authors:  Akio Kimura; Akira Takekoshi; Takayoshi Shimohata
Journal:  Brain Sci       Date:  2022-03-29

6.  Autoimmune glial fibrillary acidic protein astrocytopathy in children: a retrospective study.

Authors:  Xiamei Zhuang; Ke Jin; Xiaoming Li; Junwei Li
Journal:  Eur J Med Res       Date:  2022-01-22       Impact factor: 2.175

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.